Nick Cheshire (London, UK) interviews Matt Thompson (London, UK) on the future of endovascular aneurysm sealing (EVAS) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA).
Thompson, a former vascular surgeon who now works for a top device manufacturing company, discusses some of the issues with his firm’s Nellix EVAS system, which include long-term stent migration, and the company’s response – which Thompsons notes was to alter the anatomical indications for use of the product.
He explains that the Nellix story was a “rollercoaster” as, while the device was quickly adopted, it had started seeing failure modes after two years of implantation, which was “hugely problematic”.
Thompson concludes by discussing the future steps for EVAS and also shares his personal experience of transitioning from an academic surgeon to being a chief medical officer, which he notes “is not the leap that many people think it is”.
Subscribe to receive BLearning videos here: https://blearning.net/registration/
Add comment